U.S. Senate Moves Toward Nationwide Ban on Hemp‑Derived THC Products
Late Monday, the U.S. Senate approved language tucked into a spending bill that would effectively eliminate most hemp‑derived THC products from the market by late 2026. The provision redefines “hemp” to exclude any cannabinoids that exceed a 0.3 % total THC threshold, including THCA flower and synthetic compounds such as THC‑P and HHC. The measure now heads to the House of Representatives, where a vote could occur as early as Wednesday.
Legislative Details and Timeline
The amendment appears in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act. If enacted, the new definition will take effect 365 days after the bill’s passage, giving businesses roughly a year to adjust or cease operations. Under the revised language, “hemp” is limited to the plant Cannabis sativa and its derivatives that contain no more than 0.3 % total tetrahydrocannabinols on a dry‑weight basis. This closes the loophole that allowed merchants to sell THCA‑rich flower and synthetically produced cannabinoids outside state‑regulated marijuana channels.
Senator Rand Paul (R‑KY) warned that the change would amount to “prohibition,” stating that every hemp plant in the country would need to be destroyed to comply. The Senate passed the provision despite a last‑ditch effort by Paul to block it.
Impact on Industry and Consumers
The U.S. Hemp Roundtable estimates the hemp sector is worth approximately $28.4 billion and supports hundreds of thousands of jobs. Analysts note that the THCA flower market alone generates hundreds of millions of dollars annually. A ban of this scope would affect not only specialty hemp retailers but also major chains such as Total Wine & Spirits and Circle K, which carry hemp‑infused beverages, and alcohol producers that have experimented with hemp‑THC drinks.
Attorney Seth Goldberg, co‑chair of the cannabis and hemp practice at Pashman Stein Walder Hayden, advised businesses to begin contingency planning. He emphasized that companies should assess how the loss of the current Farm Bill safe harbor will affect product formulation, distribution, and compliance with state laws that may be overridden by the federal redefinition.
Reactions from Stakeholders
Support for the ban has come from sectors that view hemp‑derived THC as an unregulated competitor. Regulated cannabis multistate operators, including Jushi Holdings, have welcomed the move, arguing it will reduce “bad actors” exploiting the 2018 Farm Bill loophole. Trent Woloveck, Jushi’s chief strategy officer, described the change as a long‑overdue cleanup that will allow the legal cannabis industry to normalize without unfair competition.
Conversely, hemp advocates criticized the process as opaque and damaging to small businesses. Steven Brown, CEO of Minnesota‑based Nothing But Hemp, called the maneuver “sneaky” and warned that established alcohol and medical marijuana companies now see hemp as a threat rather than a complementary market segment. Brewers such as Omar Ansari of Surly Brewing Co. expressed concern that the ban will pull the rug out from under emerging product lines that have responded to shifting consumer preferences.
State attorneys general have also weighed in; in late October, 39 attorneys general urged federal lawmakers to close the loophole and establish a clear regulatory framework for intoxicating hemp products.
Looking Ahead
As the provision advances to the House, industry participants are monitoring developments closely. Should the House approve the language and the president sign the spending bill, the hemp‑derived THC market will face a federal prohibition that could reshape product availability, investment patterns, and state‑federal regulatory dynamics. Stakeholders on all sides agree that the outcome will have lasting repercussions for the broader cannabis ecosystem.
For ongoing coverage and analysis, see the original report from MJBizDaily: Here.
